BIOMAT Database Logo BIOMAT Database Logo

[Combined treatment of malignant bone tumors. I. Principles and therapeutic trends]. 1978

K Schellnack, and G Regling

UI MeSH Term Description Entries
D007166 Immunosuppressive Agents Agents that suppress immune function by one of several mechanisms of action. Classical cytotoxic immunosuppressants act by inhibiting DNA synthesis. Others may act through activation of T-CELLS or by inhibiting the activation of HELPER CELLS. While immunosuppression has been brought about in the past primarily to prevent rejection of transplanted organs, new applications involving mediation of the effects of INTERLEUKINS and other CYTOKINES are emerging. Immunosuppressant,Immunosuppressive Agent,Immunosuppressants,Agent, Immunosuppressive,Agents, Immunosuppressive
D009858 Oncogenic Viruses Viruses that produce tumors. Tumor Viruses,Oncogenic Virus,Tumor Virus,Virus, Oncogenic,Virus, Tumor,Viruses, Oncogenic,Viruses, Tumor
D001859 Bone Neoplasms Tumors or cancer located in bone tissue or specific BONES. Bone Cancer,Cancer of Bone,Cancer of the Bone,Neoplasms, Bone,Bone Neoplasm,Neoplasm, Bone
D002648 Child A person 6 to 12 years of age. An individual 2 to 5 years old is CHILD, PRESCHOOL. Children
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D000970 Antineoplastic Agents Substances that inhibit or prevent the proliferation of NEOPLASMS. Anticancer Agent,Antineoplastic,Antineoplastic Agent,Antineoplastic Drug,Antitumor Agent,Antitumor Drug,Cancer Chemotherapy Agent,Cancer Chemotherapy Drug,Anticancer Agents,Antineoplastic Drugs,Antineoplastics,Antitumor Agents,Antitumor Drugs,Cancer Chemotherapy Agents,Cancer Chemotherapy Drugs,Chemotherapeutic Anticancer Agents,Chemotherapeutic Anticancer Drug,Agent, Anticancer,Agent, Antineoplastic,Agent, Antitumor,Agent, Cancer Chemotherapy,Agents, Anticancer,Agents, Antineoplastic,Agents, Antitumor,Agents, Cancer Chemotherapy,Agents, Chemotherapeutic Anticancer,Chemotherapy Agent, Cancer,Chemotherapy Agents, Cancer,Chemotherapy Drug, Cancer,Chemotherapy Drugs, Cancer,Drug, Antineoplastic,Drug, Antitumor,Drug, Cancer Chemotherapy,Drug, Chemotherapeutic Anticancer,Drugs, Antineoplastic,Drugs, Antitumor,Drugs, Cancer Chemotherapy

Related Publications

K Schellnack, and G Regling
Current trends in the diagnosis and treatment of malignant bone tumors.
November 1983, Clinical orthopaedics and related research,
K Schellnack, and G Regling
[Primary malignant bone tumors: therapeutic methods].
September 1972, Schweizerische medizinische Wochenschrift,
K Schellnack, and G Regling
MALIGNANT BONE TUMORS; A THERAPEUTIC APPROACH.
October 1964, The American journal of orthopedics,
K Schellnack, and G Regling
[Orthopedic rehabilitation of children after combined treatment of malignant bone tumors].
March 1990, Ortopediia travmatologiia i protezirovanie,
K Schellnack, and G Regling
[Principles of cytostatic treatment of malignant tumors].
March 1968, Der Landarzt,
K Schellnack, and G Regling
[The principles and trends of development of contemporary radiotherapy of malignant tumors].
August 1960, Khirurgiia,
K Schellnack, and G Regling
[Treatment principles and methods in malignant brain tumors].
January 1982, Vestnik Akademii meditsinskikh nauk SSSR,
K Schellnack, and G Regling
[Combined treatment of malignant kidney tumors].
June 1988, Meditsinskaia radiologiia,
K Schellnack, and G Regling
[Combined treatment of malignant ovarian tumors].
January 1989, Voprosy onkologii,
K Schellnack, and G Regling
[Drug treatment principles in malignant tumors of children].
January 1983, Fel'dsher i akusherka,
Copied contents to your clipboard!